If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackbird PLC Regulatory News (BIRD)

Share Price Information for Blackbird PLC (BIRD)

Share Price is delayed by 15 minutes
Get Live Data
1.75    0.00 (0.00%)
Bid:
1.50
Ask:
2.00
Spread: 0.50 (33.333%)
Market Cap: £8.40m
BIRD Live PriceLast checked at - London Stock Exchange

Intraday Blackbird PLC Share Chart

Holding(s) in Company

9 Dec 2016 07:00

RNS Number : 3857R
Forbidden Technologies PLC
09 December 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

Forbidden Technologies plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Type 1 disclosure as per the Transparency Directive II Regulation

ü

3. Full name of person(s) subject to thenotification obligation:

Schroders plc & Schroder Investment Management Limited

4. Full name of shareholder(s)  (if different from 3.):

5. Date of the transaction and date onwhich the threshold is crossed orreached:

06.12.16

6. Date on which issuer notified:

08.12.16

7. Threshold(s) that is/are crossed orreached:

From 11% - 10%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

17,924,681

 

17,924,681

 

16,629,264

 

N/A

 

16,629,264

 

N/A

 

10.524%

 

Ordinary

 

GB0004740477

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

16,629,264

10.524%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

Schroder Investment Management Limited 16,629,264 10.524%

 

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issue share capital amount 158,010,449.

14. Contact name:

Shaheen Hussain

15. Contact telephone number:

+44 207 658 6000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBIBDDUGGBGLI
Date   Source Headline
30th Jun 20264:30 pmRNSBlock admission six monthly return
10th Jun 20262:11 pmRNSResult of AGM
10th Jun 20267:00 amRNSChair’s Annual General Meeting statement
15th May 20267:00 amRNSelevate.io update, notice of AGM, accounts posting
8th Apr 20269:13 amRNS-Relevate.io integrated Epidemic Sound music library
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSFinal Results
16th Feb 20267:00 amRNSNotice of Results and Investor Presentation
2nd Feb 20267:00 amRNS-Relevate.io launches new structured pricing tiers
30th Jan 20265:00 pmRNSTotal Voting Rights
28th Jan 20267:00 amRNS-Relevate.io teams up with NatWest Accelerator
23rd Jan 20267:00 amRNS-Relevate.io releases subtitles and transcriptions
19th Jan 20265:58 pmRNSHolding(s) in Company
7th Jan 20267:00 amRNS-Relevate.io partners with Epidemic Sound
31st Dec 202512:30 pmRNSBlock admission six monthly return
31st Dec 202512:30 pmRNSBlock admission six monthly return
18th Dec 20257:00 amRNSSubscription to raise £500,000
11th Nov 20257:00 amRNSBill Roberts joins as an adviser to the Board
5th Nov 20257:00 amRNS-Relevate.io expands AI capabilities and adds tokens
29th Sep 20257:00 amRNSInterim Results
26th Sep 20257:00 amRNS-Relevate.io partners with NY Chamber of Commerce
24th Sep 20258:45 amRNSHolding(s) in Company
11th Sep 202512:00 pmRNSChange of website
10th Sep 20257:00 amRNS-Relevate.io attends Ideas Fest
3rd Sep 20257:00 amRNS-Relevate.io partners with Enterprise Nation
27th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
18th Aug 20257:00 amRNS-Relevate.io collaboration with Barclays Eagle Labs
12th Aug 20257:00 amRNSGrant of share options
7th Aug 20257:00 amRNS-RContract Win
31st Jul 20255:00 pmRNSTotal Voting Rights
28th Jul 20252:19 pmRNSHolding(s) in Company
25th Jul 20257:00 amRNS-RFurther product development of elevate.io
24th Jul 202511:16 amRNSResult of General Meeting and Total Voting Rights
9th Jul 20253:01 pmRNSHolding(s) in Company
7th Jul 20259:49 amRNSResult of Retail Offer and Notice of GM
3rd Jul 20257:05 amRNSRetail Offer to raise up to £200,000
3rd Jul 20257:00 amRNSPlacing and Subscription to raise £2.0 million
30th Jun 20255:37 pmRNSBlock admission six monthly return
18th Jun 20255:10 pmRNSResult of AGM
18th Jun 20257:00 amRNSAGM Statement
14th May 20257:00 amRNSNotice of AGM and posting of Annual Report
12th May 20257:00 amRNSelevate.io update
24th Apr 20253:44 pmRNSHolding(s) in Company
24th Apr 20257:00 amRNSBoard Change
4th Mar 20257:00 amRNSFinal Results
13th Feb 20257:00 amRNSNotice of Results and Investor Presentation
10th Feb 20257:00 amRNSelevate.io launches Creator payment plan
6th Feb 202512:50 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSLisher joins elevate.io GTM implementation
31st Dec 202412:30 pmRNSBlock admission six monthly return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.